KLC1 and central nervous system cancer: In this study, we investigated the detailed molecular signaling pathway triggered by KLC1-ROS1 fusion in glioma cells and discovered that JAK-STAT signaling was specifically activated in KLC1-ROS1 fusion-expressing human glioma cells.